Skip to main content
NCBI home page
Frontiers in Neuroscience logoLink to Frontiers in Neuroscience
. 2017 May 26;11:295. doi: 10.3389/fnins.2017.00295

Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human

Dimitri Ryczko 1,†, Réjean Dubuc 1,2,*
PMCID: PMC5445171  PMID: 28603482

Abstract

In vertebrates, dopamine neurons are classically known to modulate locomotion via their ascending projections to the basal ganglia that project to brainstem locomotor networks. An increased dopaminergic tone is associated with increase in locomotor activity. In pathological conditions where dopamine cells are lost, such as in Parkinson's disease, locomotor deficits are traditionally associated with the reduced ascending dopaminergic input to the basal ganglia. However, a descending dopaminergic pathway originating from the substantia nigra pars compacta was recently discovered. It innervates the mesencephalic locomotor region (MLR) from basal vertebrates to mammals. This pathway was shown to increase locomotor output in lampreys, and could very well play an important role in mammals. Here, we provide a detailed account on the newly found dopaminergic pathway in lamprey, salamander, rat, monkey, and human. In lampreys and salamanders, dopamine release in the MLR is associated with the activation of reticulospinal neurons that carry the locomotor command to the spinal cord. Dopamine release in the MLR potentiates locomotor movements through a D1-receptor mechanism in lampreys. In rats, stimulation of the substantia nigra pars compacta elicited dopamine release in the pedunculopontine nucleus, a known part of the MLR. In a monkey model of Parkinson's disease, a reduced dopaminergic innervation of the brainstem locomotor networks was reported. Dopaminergic fibers are also present in human pedunculopontine nucleus. We discuss the conserved locomotor role of this pathway from lamprey to mammals, and the hypothesis that this pathway could play a role in the locomotor deficits reported in Parkinson's disease.

Keywords: locomotion, brainstem, dopamine, mesencephalic locomotor region, substantia nigra pars compacta, pedunculopontine nucleus, conservation, Parkinson's disease

Ascending dopaminergic pathway and locomotion

Dopaminergic neurons degenerate in patients with Parkinson's disease (PD), resulting in serious motor dysfunctions including locomotor deficits (falls, gait freezing, dysfunctional turning), which constitute major problems in advanced forms of the disease (Stack and Ashburn, 2008, for review see Bloem et al., 2004). These locomotor deficits are traditionally associated with a loss of the ascending dopaminergic projections from the substantia nigra pars compacta (SNc) to the basal ganglia (Carlsson et al., 1958; Carlsson, 1959; Sano et al., 1959; Poirier and Sourkes, 1965; Sourkes and Poirier, 1965; Albin et al., 1989; Ehringer and Hornykiewicz, 1998; Kravitz et al., 2010; Roseberry et al., 2016, for review see Fahn, 2015). In turn, the basal ganglia project down to the Mesencephalic Locomotor Region (MLR), a brainstem region that controls locomotion in vertebrates (Shik et al., 1966; for review see Ryczko and Dubuc, 2013, Figure 1). The MLR was initially found in cats to initiate locomotion and control its frequency and intensity (Shik et al., 1966). It was later identified in lamprey (Sirota et al., 2000), salamander (Cabelguen et al., 2003), stingray (Bernau et al., 1991), bird (Sholomenko et al., 1991), rat (Garcia-Rill et al., 1987), mouse (Lee et al., 2014; Roseberry et al., 2016), rabbit (Musienko et al., 2008), guinea-pig (Marlinsky and Voitenko, 1991), and monkey (Eidelberg et al., 1981; Karachi et al., 2010; Goetz et al., 2016a). In basal vertebrates, the MLR comprises the laterodorsal tegmental nucleus and the pedunculopontine nucleus (PPN). In mammals, it comprises the PPN, but also the cuneiform nucleus (CnF). In humans, damage to the MLR is associated with locomotor deficits (Masdeu et al., 1994; Kuo et al., 2008; Demain et al., 2014). The MLR is explored as a target for deep brain stimulation to improve locomotor function in Parkinsonian patients (Plaha and Gill, 2005; for review see Hamani et al., 2016a,b).

Figure 1.

Figure 1

Open in a new tab

The descending dopaminergic pathway recently uncovered in vertebrates. Schematic representation of the connectivity between the meso-diencephalic dopamine cells, the basal ganglia, the Mesencephalic Locomotor Region (MLR), the reticulospinal cells (RS), and the Central Pattern Generator (CPG) for locomotion. The meso-diencephalic dopamine cells refer to the posterior tuberculum in basal vertebrates and to the substantia nigra pars compacta in mammals. For convenience, the well-established direct and indirect pathways within the basal ganglia are not illustrated. (Adapted from (Le Ray et al., 2011). No permission is required for this reproduction).

The ascending dopaminergic projections mostly target the striatum, a major entry of the basal ganglia. These projections favor locomotion initiation by increasing the excitability of D1-expressing striatal neurons of the direct pathway, and this reduces the tonic inhibition sent by the output stations of the basal ganglia to the MLR. In parallel, dopamine decreases the excitability of D2-expressing striatal neurons of the indirect pathway. This also contributes to disinhibit the MLR, and initiate movement (Albin et al., 1989; Kravitz et al., 2010; Freeze et al., 2013; Roseberry et al., 2016). Such organization is conserved within the basal ganglia from lamprey to mammals (see Grillner and Robertson, 2016). Once disinhibited, the MLR initiates locomotion by sending descending excitatory inputs to reticulospinal neurons, which activate the central pattern generator for locomotion (Figure 1, cat: Orlovskii, 1970; Steeves and Jordan, 1980; Garcia-Rill and Skinner, 1987a,b; Noga et al., 1988, 1991; rat: Bachmann et al., 2013; bird: Sholomenko et al., 1991; lamprey: Buchanan and Grillner, 1987; Brodin et al., 1988; Ohta and Grillner, 1989; Brocard and Dubuc, 2003; Le Ray et al., 2003; mouse: Bretzner and Brownstone, 2013; salamander: Ryczko et al., 2016b). MLR glutamatergic neurons are of primary importance to activate reticulospinal neurons and elicit locomotion (lamprey: Brocard and Dubuc, 2003, salamander: Ryczko et al., 2016b, mouse: Lee et al., 2014; Roseberry et al., 2016). MLR cholinergic neurons provide additional excitation to reticulospinal cells (lamprey: Le Ray et al., 2003; Smetana et al., 2010; mouse: Roseberry et al., 2016). The functional significance of this circuitry was elegantly summed in a mouse study, in which it was shown that ascending dopaminergic pathways to the basal ganglia indirectly control MLR glutamatergic cells and locomotion (Roseberry et al., 2016). The loss of the ascending dopaminergic pathway is thus considered the main cause of locomotor deficits in PD.

A new descending dopaminergic pathway has been unraveled

There was some indication in the literature that in addition to their ascending projections, dopaminergic cells also sent direct descending projections to brainstem locomotor networks. In rat, dopamine was detected using radiometric assays or microdialysis in the CnF (Versteeg et al., 1976; Saavedra et al., 1979) and PPN (Steiniger and Kretschmer, 2003) that are both part of the MLR in mammals (see Ryczko and Dubuc, 2013). Moreover, dopaminergic fibers were detected in rat brainstem using immunohistochemistry (Kitahama et al., 2000). In monkey, dopaminergic terminals were found in proximity with cholinergic cells of the PPN and CnF (Rolland et al., 2009). The origin of this dopaminergic projection remained unknown, but tracing studies mentioned a descending projection from the SNc to the PPN in rat (Beckstead et al., 1979; Semba and Fibiger, 1992; Steininger et al., 1992; Ichinohe et al., 2000) and in cat (Edley and Graybiel, 1983). The presence of such descending input was also supported by recordings of short latency antidromic activation of SNc neurons following PPN stimulation in rat (Scarnati et al., 1984, 1987).

We investigated the origin of the dopaminergic innervation of the MLR in vertebrates. In lamprey (Ryczko et al., 2013) and salamander (Ryczko et al., 2016a), dopaminergic fibers were found around MLR cholinergic cells, a conserved landmark of the MLR (see Ryczko and Dubuc, 2013). We identified the origin of this dopaminergic innervation in lamprey (Figure 2G, Ryczko et al., 2013; see also Perez-Fernandez et al., 2014) and in salamander (Figure 2H, Ryczko et al., 2016a) as a diencephalic dopaminergic region called the posterior tuberculum. This region sends ascending projection to the striatum, and is considered homologous to the mammalian SNc and/or ventral tegmental area (Marin et al., 1997; Pombal et al., 1997; Puelles and Verney, 1998; Smeets et al., 2000; Rink and Wullimann, 2001; Blin et al., 2008; for review see Yamamoto and Vernier, 2011; Wullimann, 2014). We then found that such “new pathway” (Figure 1) is conserved in higher vertebrates. In rat, PPN cholinergic cells were innervated by dopaminergic fibers (Ryczko et al., 2016a). Using virogenetic tracing, we found that the dopaminergic innervation of the rat MLR originates from the SNc and to a lesser extent the retrorubral field (Figure 2I, Ryczko et al., 2016a). This was confirmed using conventional tracers coupled with immunofluorescence experiments (Ryczko et al., 2016a). While only a few dopamine neurons sent both an ascending projection to the striatum and a descending one to the MLR in lampreys and salamanders, numerous SNc dopamine neurons sent both ascending and descending projections in rats. The proportion of the ascending dopaminergic projection may have increased during evolution due to the expansion of the basal ganglia (see Grillner and Robertson, 2016). We then found in the human brain that PPN cholinergic cells are surrounded by dopaminergic fibers (Figures 2J–L, Ryczko et al., 2016a), indicating that the innervation of the MLR is conserved in vertebrates.

Figure 2.

Figure 2

Open in a new tab

The descending dopaminergic (DA) pathway is conserved from basal vertebrates to mammals. (A–F) Dopamine is released in the MLR after chemical stimulation of DA cells in the posterior tuberculum (PT) of lampreys (A,D) or salamanders (in vitro isolated brain) (B,E), or after electrical stimulation of the substantia nigra pars compacta (SNc) in rats (anesthetized) (C,F). (D–F) mean ± sem is illustrated. (G) Lamprey tyrosine hydroxylase (TH)-containing cells (red) in the PT and cells projecting to the MLR (green) with arrows indicating double labeled cells. (H) Salamander TH-containing cells (red) in the PT and cells projecting to the MLR (green) with arrows indicating double labeled cells. (I) DA cells in the SNc retrogradely labeled by an injection of a Cre-dependent adeno-associated virus encoding for the enhanced yellow fluorescent protein (EYFP, green) in the MLR of transgenic rats expressing the Cre-recombinase in TH neurons as shown by immunostaining against TH (red). (J–L) DA innervation of the human MLR. (J–L) The location of cholinergic cells (choline acetyltransferase-positive, ChAT) of the pedunculopontine nucleus (PPN), part of the MLR, is indicated. (L) Fibers containing the dopamine active transporter (DAT, red, highlighted by arrows) in proximity with cholinergic cells (ChAT, green) in the PPN. IC, inferior colliculus; SC, superior colliculus. (Panels A,D,G adapted from D. Ryczko, S. Gratsch, F. Auclair, C. Dube, S. Bergeron, M.H. Alpert, J.J. Cone, M.F. Roitman, S. Alford, and R. Dubuc, Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proceedings of the National Academy of Sciences of the United States of America 110 (2013) E3235–E3242. No permission is required for this reproduction; panels B,C,E,F,H,I,J–L adapted from D. Ryczko, J.J. Cone, M.H. Alpert, L. Goetz, F. Auclair, C. Dube, M. Parent, M.F. Roitman, S. Alford, and R. Dubuc, A descending dopamine pathway conserved from basal vertebrates to mammals. Proceedings of the National Academy of Sciences of the United States of America 113 (2016) E2440–E2449. No permission is required for this reproduction).

The descending dopaminergic pathway was shown to release dopamine in the MLR with fast-scan voltammetry (Ryczko et al., 2016a). Stimulation of the dopaminergic region evoked dopamine release in the MLR in vitro in lamprey (Figures 2A,D, Ryczko et al., 2013) and in salamander (Figures 2B,E, Ryczko et al., 2016a). In rat, SNc stimulation evoked dopamine release in the PPN in vivo (Figures 2C,F) that was potentiated by intraperitoneal amphetamine injection (Ryczko et al., 2016a). Altogether, these results established that the descending dopaminergic pathway is conserved and functional from basal vertebrates (lampreys, salamanders) to mammals (rats).

The role of the descending dopaminergic pathway in modulating locomotor activity was examined in two basal vertebrates. In lampreys and salamanders, stimulation of the dopamine region evoked dopamine release in the MLR, associated with activation of reticulospinal cells, which carry the locomotor command to the spinal cord (Ryczko et al., 2013, 2016a). There was a precise correlation in time linking MLR dopamine release and the activation of reticulospinal cells. The behavioral role of dopamine release in the MLR was examined in a lamprey semi-intact preparation (Ryczko et al., 2013), where the brain is exposed while the body swims as reported in many studies from our group (Sirota et al., 2000; Viana Di Prisco et al., 2000; Le Ray et al., 2003; Brocard et al., 2005, 2010; Gravel et al., 2007; Menard et al., 2007; Derjean et al., 2010; Smetana et al., 2010; Gariepy et al., 2012; Juvin et al., 2016). Stimulation of the dopaminergic region elicited reticulospinal activity together with locomotion, and microinjections of a D1 antagonist in the MLR decreased the number of locomotor cycles, the frequency of locomotor movements, and the duration of the locomotor bout (Ryczko et al., 2013). Conversely, microinjection of dopamine in the MLR had an opposite effect (Ryczko et al., 2013). In mammals, whether MLR dopamine release is associated with activation of the locomotor system remains to be addressed. The observation that amphetamine increases dopamine release in the rat MLR (Ryczko et al., 2016a) suggests an involvement of the descending dopaminergic pathway in the well-characterized increase in locomotor activity elicited by dopaminergic drugs (e.g., psychostimulants, L-DOPA).

The mechanisms through which dopamine potentiates MLR cell activity remain to be determined. It is possible that MLR dopamine enhances locomotor output by potentiating glutamatergic inputs to the MLR. In support of this, stimulation of the dopaminergic region evokes fast excitatory synaptic inputs in MLR cells in lampreys (Gariepy et al., 2012; Ryczko et al., 2013). This fast input could be glutamatergic and monosynaptic according to anatomical and electrophysiological data (Derjean et al., 2010). Future research should determine whether the two transmitters cooperate pre- and/or post-synaptically, and establish the role of dopaminergic inputs on intrinsic properties of MLR cells.

Possible role of the descending dopaminergic pathway in PD

There is accumulating evidence indicating that the MLR plays a similar role in humans as described in animal models. Moreover, it appears that some of the locomotor deficits observed in PD can be attributed to changes in the brainstem locomotor circuitry including the MLR. The PPN and CnF, both parts of the MLR, are activated in healthy individuals when they are asked to imagine that they are walking (Jahn et al., 2008; Snijders et al., 2011; Karachi et al., 2012; Peterson et al., 2014; Tattersall et al., 2014). In Parkinsonian subjects, similar observations were reported (Piallat et al., 2009; Lau et al., 2015; for review see Bohnen and Jahn, 2013). PPN activity increases during walking, and is modulated by L-DOPA with increase in alpha band (5–12 Hz) and decrease in beta (13–35) and gamma (65–90 Hz) bands (Fraix et al., 2013). Gait freezing is associated with a decreased alpha band activity in the PPN (Thevathasan et al., 2012). Motor arrests are associated with decreased blood oxygen levels in the MLR (Shine et al., 2013). Neuronal losses were reported in the PPN of patients with PD or progressive supranuclear palsy (Hirsch et al., 1987; Zweig et al., 1987, 1989; Jellinger, 1988). In PD this includes degeneration of cholinergic (Rinne et al., 2008; Karachi et al., 2010; Pienaar et al., 2013), GABAergic and glycinergic cells (Pienaar et al., 2013). Neuroimaging indicates that locomotor deficits in PD patients are associated with additional MLR abnormalities (notably in the PPN), including altered connectivity between the MLR, thalamus, and motor cortical regions (Fling et al., 2013, 2014), abnormal microstructure (Vercruysse et al., 2015; Youn et al., 2015; Wang et al., 2016), atrophy of the MLR gray matter (Snijders et al., 2011; Fioravanti et al., 2015) and abnormal metabolic activity following a walking task (Tard et al., 2015). Additionally, anatomopathological studies revealed the presence in the MLR of alpha-synuclein immuno-reactive Lewy Bodies (e.g., Seidel et al., 2015), and mitochondrial abnormalities (Pienaar et al., 2013) in PD. The severity of the locomotor deficits increases with the amplitude of PPN damage as captured by neuroimaging (Canu et al., 2015). These data are consistent with those showing that non-Parkinsonian individuals with MLR lesion display locomotor deficits (Masdeu et al., 1994; Kuo et al., 2008; Yeo et al., 2012), and that elderly with high level gait and balance disorders display midbrain gray matter atrophy including in the MLR (Demain et al., 2014). Finally, more and more studies point to the involvement of the PPN in the locomotor improvements related to deep brain stimulation of the subthalamic nucleus (human: Holiga et al., 2015; Knight et al., 2015; Weiss et al., 2015), which sends excitatory glutamatergic input to the PPN (e.g., Breit et al., 2001; Neagu et al., 2013; see Ryczko and Dubuc, 2013).

The benefits of MLR deep brain stimulation on locomotor function in PD (Plaha and Gill, 2005) are variable, from promising to modest (for recent studies, see Schrader et al., 2013; Mazzone et al., 2014; Holiga et al., 2015; Liu et al., 2015; Nosko et al., 2015; Welter et al., 2015) or unsustained benefits over the years (Mestre et al., 2016). This variability could be attributed to degeneration of MLR cells and to the variability of the brainstem anatomy from patient to patient (Mazzone et al., 2013). Reviewing the fast-growing body of literature on this neurosurgical approach is beyond the scope of the present review (for recent reviews, see Collomb-Clerc and Welter, 2015; DeLong and Wichmann, 2015; Fasano et al., 2015; Golestanirad et al., 2016; Rowe et al., 2016; Snijders et al., 2016). Several authors pointed out that adequate control trials and more standardization are needed before concluding on the efficacy of MLR deep brain stimulation (Windels et al., 2015; for review, see Hamani et al., 2016a,b).

The dopaminergic innervation of the PPN and CnF dramatically degenerates in a monkey model of PD (Rolland et al., 2009). The degeneration elicited by MPTP was even more marked in aged monkeys, maybe underlining the increasing fragility of this innervation over lifetime. The loss of dopaminergic innervation in the MLR could contribute to the pathophysiology of PD in several ways. If the role of the descending dopaminergic pathway to the MLR is conserved in higher vertebrates, locomotor deficits in PD may result, at least in part, from the loss of excitatory dopaminergic inputs to the MLR. This would lead to a reduced amplification of descending locomotor commands. Conversely, the descending dopaminergic pathway may improve locomotor function evoked by L-DOPA in people with PD (e.g., Moore et al., 2008; Chastan et al., 2009; Bryant et al., 2011a,b) by increasing the excitability of MLR cells. Importantly, locomotor deficits that are unresponsive to L-DOPA are associated with MLR degeneration (Chastan et al., 2009; Karachi et al., 2010; Snijders et al., 2011). It is thus possible that the beneficial effects of increasing dopamine release in the MLR with L-DOPA, or of stimulating MLR cells with dopaminergic agonists could improve locomotor function before MLR cells are lost in large number.

It is also possible that the loss of dopaminergic inputs to the MLR may disrupt the excitability of MLR cells, causing them to eventually degenerate. Such transneuronal degeneration can occur anterogradely or retrogradely and is characterized by a “structural deterioration of areas remote from the initial insult” (Fornito et al., 2015). This phenomenon was shown in the visual (e.g., Hubel and Wiesel, 1970; Herbin et al., 1999) and olfactory systems (e.g., Pinching and Powell, 1971). Transneuronal degeneration was also shown to damage dopaminergic neurons following striatal lesion (Macaya et al., 1994; Marti et al., 1997; El-Khodor and Burke, 2002; Canudas et al., 2005) and was proposed to contribute to PD (Pedersen and Schmidt, 2000). It was also proposed to occur in other neurodegenerative diseases including Alzheimer's disease and amyotrophic lateral sclerosis (see Fornito et al., 2015). The multiple alterations in the MLR in PD are compatible with such phenomenon (see Fornito et al., 2015). The reciprocal projections between the SNc and the PPN (McGeer and McGeer, 1984; Lavoie and Parent, 1994; Ryczko et al., 2013, 2016a; Perez-Fernandez et al., 2014) could also contribute to potentiate the transneuronal degeneration process. Nigral dopamine cell degeneration would cause a loss of the dopaminergic input to the MLR, causing MLR cells to degenerate. In turn, degeneration of PPN cholinergic and glutamatergic cells projecting to the nigral dopamine neurons would contribute to nigral dopamine cell loss. Studies in rat and monkey indicate that destruction of dopamine cells causes degeneration of MLR cholinergic cells (Pienaar et al., 2015b; Bensaid et al., 2016). Conversely, lesion of PPN cholinergic neurons induces a loss of dopaminergic nigral neurons (Bensaid et al., 2016). Finally, lesion of nigral dopaminergic neurons followed by lesion of PPN cholinergic cells induces a more dramatic degeneration of PPN cholinergic cells (Bensaid et al., 2016), suggesting that the two lesions interact to create a transneuronal degeneration loop. Stabilization of the reciprocal interactions between dopamine and cholinergic neurons could be a promising avenue to alleviate degeneration of the two systems. Interestingly, activation of PPN cholinergic cells with designer receptors exclusively activated by designer drugs (DREADDs) improves locomotor function in a rat model of PD (Pienaar et al., 2015a). It would be interesting to determine whether this approach would decrease degeneration of cholinergic and dopaminergic cells.

The descending dopaminergic projections to the PPN could also regulate other important functions such as cognition, sleep (Stefani et al., 2013; Karachi and Francois, 2017), modulation of visual inputs during locomotion (Lee et al., 2014), arousal state (Garcia-Rill et al., 2015a,b; Goetz et al., 2016b), motivation, and reward (Xiao et al., 2016; Yoo et al., 2017). How the descending dopaminergic input to the PPN influences these functions should be the subject of future research. Interestingly, the multifunctional aspects of the MLR, well established in lampreys (i.e., regulation of locomotion, respiration, control of sensory inputs, see Ryczko and Dubuc, 2013), are mirrored by the multifunctionality of the PPN in mammals.

In conclusion, studies carried out in two basal vertebrates (lampreys and salamanders) allowed us to discover a direct dopaminergic projection from the SNc down to the MLR. Several lines of evidence indicate that this new dopaminergic pathway is functional in rats, and could also be present in humans. Future research should address whether the descending dopaminergic pathway potentiates locomotion in mammals as in basal vertebrates, whether it contributes to other PPN functions, and whether this dopaminergic innervation degenerates in PD patients.

Author contributors

DR and RD wrote the article.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Danielle Veilleux for her technical assistance and Frédéric Bernard for his help with the graphics.

Footnotes

Funding. This work was supported by the Canadian Institutes of Health Research Grant 15129 (to RD); the Natural Sciences and Engineering Research Council of Canada Grant 217435 (to RD); the Great Lakes Fishery Commission Grants 54011, 54021 and 54035 (to RD); the Parkinson Society Canada Grant 2011-11 (to RD); the Fonds de Recherche du Québec—Santé (FRQS: Groupe de Recherche sur le Système Nerveux Central, GRSNC, 5249). DR received fellowships from FRQS and the GRSNC Jasper fellowship.

References

  1. Albin R. L., Young A. B., Penney J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366–375. 10.1016/0166-2236(89)90074-X [DOI] [PubMed] [Google Scholar]
  2. Bachmann L. C., Matis A., Lindau N. T., Felder P., Gullo M., Schwab M. E. (2013). Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci. Transl. Med. 5:208ra146. 10.1126/scitranslmed.3005972 [DOI] [PubMed] [Google Scholar]
  3. Beckstead R. M., Domesick V. B., Nauta W. J. (1979). Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191–217. 10.1016/0006-8993(79)91001-1 [DOI] [PubMed] [Google Scholar]
  4. Bensaid M., Michel P. P., Clark S. D., Hirsch E. C., Francois C. (2016). Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease. Exp. Neurol. 275(Pt 1), 209–219. 10.1016/j.expneurol.2015.11.004 [DOI] [PubMed] [Google Scholar]
  5. Bernau N. A., Puzdrowski R. L., Leonard R. B. (1991). Identification of the midbrain locomotor region and its relation to descending locomotor pathways in the Atlantic stingray, Dasyatis sabina. Brain Res. 557, 83–94. 10.1016/0006-8993(91)90119-G [DOI] [PubMed] [Google Scholar]
  6. Blin M., Norton W., Bally-Cuif L., Vernier P. (2008). NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain. Mol. Cell. Neurosci. 39, 592–604. 10.1016/j.mcn.2008.08.006 [DOI] [PubMed] [Google Scholar]
  7. Bloem B. R., Hausdorff J. M., Visser J. E., Giladi N. (2004). Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov. Disord. 19, 871–884. 10.1002/mds.20115 [DOI] [PubMed] [Google Scholar]
  8. Bohnen N. I., Jahn K. (2013). Imaging: what can it tell us about parkinsonian gait? Mov. Disord. 28, 1492–1500. 10.1002/mds.25534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Breit S., Bouali-Benazzouz R., Benabid A. L., Benazzouz A. (2001). Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur. J. Neurosci. 14, 1833–1842. 10.1046/j.0953-816x.2001.01800.x [DOI] [PubMed] [Google Scholar]
  10. Bretzner F., Brownstone R. M. (2013). Lhx3-Chx10 reticulospinal neurons in locomotor circuits. J. Neurosci. 33, 14681–14692. 10.1523/JNEUROSCI.5231-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brocard F., Bardy C., Dubuc R. (2005). Modulatory effect of substance P to the brain stem locomotor command in lampreys. J. Neurophysiol. 93, 2127–2141. 10.1152/jn.00401.2004 [DOI] [PubMed] [Google Scholar]
  12. Brocard F., Dubuc R. (2003). Differential contribution of reticulospinal cells to the control of locomotion induced by the mesencephalic locomotor region. J. Neurophysiol. 90, 1714–1727. 10.1152/jn.00202.2003 [DOI] [PubMed] [Google Scholar]
  13. Brocard F., Ryczko D., Fenelon K., Hatem R., Gonzales D., Auclair F., et al. (2010). The transformation of a unilateral locomotor command into a symmetrical bilateral activation in the brainstem. J. Neurosci. 30, 523–533. 10.1523/JNEUROSCI.3433-09.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brodin L., Tossman U., Ohta Y., Ungerstedt U., Grillner S. (1988). The effect of an uptake inhibitor (dihydrokainate) on endogenous excitatory amino acids in the lamprey spinal cord as revealed by microdialysis. Brain Res. 458, 166–169. 10.1016/0006-8993(88)90511-2 [DOI] [PubMed] [Google Scholar]
  15. Bryant M. S., Rintala D. H., Hou J. G., Charness A. L., Fernandez A. L., Collins R. L., et al. (2011a). Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment. Neurol. Res. 33, 959–964. 10.1179/1743132811Y.0000000044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bryant M. S., Rintala D. H., Hou J. G., Lai E. C., Protas E. J. (2011b). Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease. NeuroRehabilitation 29, 247–252. 10.3233/NRE-2011-0700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Buchanan J. T., Grillner S. (1987). Newly identified “glutamate interneurons” and their role in locomotion in the lamprey spinal cord. Science 236, 312–314. 10.1126/science.3563512 [DOI] [PubMed] [Google Scholar]
  18. Cabelguen J. M., Bourcier-Lucas C., Dubuc R. (2003). Bimodal locomotion elicited by electrical stimulation of the midbrain in the salamander Notophthalmus viridescens. J. Neurosci. 23, 2434–2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Canu E., Agosta F., Sarasso E., Volonte M. A., Basaia S., Stojkovic T., et al. (2015). Brain structural and functional connectivity in Parkinson's disease with freezing of gait. Hum. Brain Mapp. 36, 5064–5078. 10.1002/hbm.22994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Canudas A. M., Pezzi S., Canals J. M., Pallas M., Alberch J. (2005). Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury. Brain Res. Mol. Brain Res. 134, 147–154. 10.1016/j.molbrainres.2004.11.012 [DOI] [PubMed] [Google Scholar]
  21. Carlsson A. (1959). The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11, 490–493. [PubMed] [Google Scholar]
  22. Carlsson A., Lindqvist M., Magnusson T., Waldeck B. (1958). On the presence of 3-hydroxytyramine in brain. Science 127:471. 10.1126/science.127.3296.471 [DOI] [PubMed] [Google Scholar]
  23. Chastan N., Do M. C., Bonneville F., Torny F., Bloch F., Westby G. W., et al. (2009). Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity. Mov. Disord. 24, 188–195. 10.1002/mds.22269 [DOI] [PubMed] [Google Scholar]
  24. Collomb-Clerc A., Welter M. L. (2015). Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: a systematic neurophysiological review. Neurophysiol. Clin. 45, 371–388. 10.1016/j.neucli.2015.07.001 [DOI] [PubMed] [Google Scholar]
  25. DeLong M. R., Wichmann T. (2015). Basal ganglia circuits as targets for neuromodulation in Parkinson disease. JAMA Neurol. 72, 1354–1360. 10.1001/jamaneurol.2015.2397 [DOI] [PubMed] [Google Scholar]
  26. Demain A., Westby G. W., Fernandez-Vidal S., Karachi C., Bonneville F., Do M. C., et al. (2014). High-level gait and balance disorders in the elderly: a midbrain disease? J. Neurol. 261, 196–206. 10.1007/s00415-013-7174-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Derjean D., Moussaddy A., Atallah E., St-Pierre M., Auclair F., Chang S., et al. (2010). A novel neural substrate for the transformation of olfactory inputs into motor output. PLoS Biol. 8:e1000567. 10.1371/journal.pbio.1000567 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Di Prisco G. V., Pearlstein E., Le Ray D., Robitaille R., Dubuc R. (2000). A cellular mechanism for the transformation of a sensory input into a motor command. J. Neurosci. 20, 8169–8176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Edley S. M., Graybiel A. M. (1983). The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J. Comp. Neurol. 217, 187–215. 10.1002/cne.902170207 [DOI] [PubMed] [Google Scholar]
  30. Ehringer H., Hornykiewicz O. (1998). Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism Relat. Disord. 4, 53–57. 10.1016/S1353-8020(98)00012-1 [DOI] [PubMed] [Google Scholar]
  31. Eidelberg E., Walden J. G., Nguyen L. H. (1981). Locomotor control in macaque monkeys. Brain 104, 647–663. 10.1093/brain/104.4.647-a [DOI] [PubMed] [Google Scholar]
  32. El-Khodor B. F., Burke R. E. (2002). Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J. Comp. Neurol. 452, 65–79. 10.1002/cne.10367 [DOI] [PubMed] [Google Scholar]
  33. Fahn S. (2015). The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Mov. Disord. 30, 4–18. 10.1002/mds.26102 [DOI] [PubMed] [Google Scholar]
  34. Fasano A., Aquino C. C., Krauss J. K., Honey C. R., Bloem B. R. (2015). Axial disability and deep brain stimulation in patients with Parkinson disease. Nat. Rev. Neurol. 11, 98–110. 10.1038/nrneurol.2014.252 [DOI] [PubMed] [Google Scholar]
  35. Fioravanti V., Benuzzi F., Codeluppi L., Contardi S., Cavallieri F., Nichelli P., et al. (2015). MRI correlates of Parkinson's disease progression: a voxel based morphometry study. Parkinson's Dis. 2015:378032. 10.1155/2015/378032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Fling B. W., Cohen R. G., Mancini M., Carpenter S. D., Fair D. A., Nutt J. G., et al. (2014). Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS ONE 9:e100291. 10.1371/journal.pone.0100291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Fling B. W., Cohen R. G., Mancini M., Nutt J. G., Fair D. A., Horak F. B. (2013). Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 136, 2405–2418. 10.1093/brain/awt172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fornito A., Zalesky A., Breakspear M. (2015). The connectomics of brain disorders. Nat. Rev. Neurosci. 16, 159–172. 10.1038/nrn3901 [DOI] [PubMed] [Google Scholar]
  39. Fraix V., Bastin J., David O., Goetz L., Ferraye M., Benabid A. L., et al. (2013). Pedunculopontine nucleus area oscillations during stance, stepping and freezing in Parkinson's disease. PLoS ONE 8:e83919. 10.1371/journal.pone.0083919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Freeze B. S., Kravitz A. V., Hammack N., Berke J. D., Kreitzer A. C. (2013). Control of basal ganglia output by direct and indirect pathway projection neurons. J. Neurosci. 33, 18531–18539. 10.1523/JNEUROSCI.1278-13.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Garcia-Rill E., Houser C. R., Skinner R. D., Smith W., Woodward D. J. (1987). Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus. Brain Res. Bull. 18, 731–738. 10.1016/0361-9230(87)90208-5 [DOI] [PubMed] [Google Scholar]
  42. Garcia-Rill E., Luster B., D'Onofrio S., Mahaffey S. (2015a). Arousal, motor control, and parkinson's disease. Transl. Neurosci. 6, 198–207. 10.1515/tnsci-2015-0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Garcia-Rill E., Luster B., D'Onofrio S., Mahaffey S., Bisagno V., Urbano F. J. (2015b). Pedunculopontine arousal system physiology - Deep brain stimulation (DBS). Sleep Sci. 8, 153–161. 10.1016/j.slsci.2015.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Garcia-Rill E., Skinner R. D. (1987a). The mesencephalic locomotor region. I. Activation of a medullary projection site. Brain Res. 411, 1–12. 10.1016/0006-8993(87)90675-5 [DOI] [PubMed] [Google Scholar]
  45. Garcia-Rill E., Skinner R. D. (1987b). The mesencephalic locomotor region. II. Projections to reticulospinal neurons. Brain Res. 411, 13–20. 10.1016/0006-8993(87)90676-7 [DOI] [PubMed] [Google Scholar]
  46. Gariepy J. F., Missaghi K., Chevallier S., Chartre S., Robert M., Auclair F., et al. (2012). Specific neural substrate linking respiration to locomotion. Proc. Natl. Acad. Sci. U.S.A. 109, E84–E92. 10.1073/pnas.1113002109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Goetz L., Piallat B., Bhattacharjee M., Mathieu H., David O., Chabardes S. (2016a). On the role of the pedunculopontine nucleus and mesencephalic reticular formation in locomotion in nonhuman primates. J. Neurosci. 36, 4917–4929. 10.1523/JNEUROSCI.2514-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Goetz L., Piallat B., Bhattacharjee M., Mathieu H., David O., Chabardes S. (2016b). The primate pedunculopontine nucleus region: towards a dual role in locomotion and waking state. J. Neural Transm. 123, 667–678. 10.1007/s00702-016-1577-7 [DOI] [PubMed] [Google Scholar]
  49. Golestanirad L., Elahi B., Graham S. J., Das S., Wald L. L. (2016). Efficacy and safety of pedunculopontine nuclei (PPN) deep brain stimulation in the treatment of gait disorders: a meta-analysis of clinical studies. Can. J. Neurol. Sci. 43, 120–126. 10.1017/cjn.2015.318 [DOI] [PubMed] [Google Scholar]
  50. Gravel J., Brocard F., Gariepy J. F., Lund J. P., Dubuc R. (2007). Modulation of respiratory activity by locomotion in lampreys. Neuroscience 144, 1120–1132. 10.1016/j.neuroscience.2006.10.019 [DOI] [PubMed] [Google Scholar]
  51. Grillner S., Robertson B. (2016). The basal ganglia over 500 million years. Curr. Biol. 26, R1088–R1100. 10.1016/j.cub.2016.06.041 [DOI] [PubMed] [Google Scholar]
  52. Hamani C., Aziz T., Bloem B. R., Brown P., Chabardes S., Coyne T., et al. (2016a). Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical anatomy and terminology. Stereotact. Funct. Neurosurg. 94, 298–306. 10.1159/000449010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hamani C., Lozano A. M., Mazzone P. A., Moro E., Hutchison W., Silburn P. A., et al. (2016b). Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical techniques, side effects, and postoperative imaging. Stereotact. Funct. Neurosurg. 94, 307–319. 10.1159/000449011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Herbin M., Boire D., Theoret H., Ptito M. (1999). Transneuronal degeneration of retinal ganglion cells in early hemispherectomized monkeys. Neuroreport 10, 1447–1452. 10.1097/00001756-199905140-00011 [DOI] [PubMed] [Google Scholar]
  55. Hirsch E. C., Graybiel A. M., Duyckaerts C., Javoy-Agid F. (1987). Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc. Natl. Acad. Sci. U.S.A. 84, 5976–5980. 10.1073/pnas.84.16.5976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Holiga S., Mueller K., Moller H. E., Urgosik D., Ruzicka E., Schroeter M. L., et al. (2015). Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: indications of a principal role of the brainstem. NeuroImage Clin. 9, 264–274. 10.1016/j.nicl.2015.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hubel D. H., Wiesel T. N. (1970). The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J. Physiol. 206, 419–436. 10.1113/jphysiol.1970.sp009022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ichinohe N., Teng B., Kitai S. T. (2000). Morphological study of the tegmental pedunculopontine nucleus, substantia nigra and subthalamic nucleus, and their interconnections in rat organotypic culture. Anat. Embryol. 201, 435–453. 10.1007/s004290050331 [DOI] [PubMed] [Google Scholar]
  59. Jahn K., Deutschlander A., Stephan T., Kalla R., Wiesmann M., Strupp M., et al. (2008). Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage 39, 786–792. 10.1016/j.neuroimage.2007.09.047 [DOI] [PubMed] [Google Scholar]
  60. Jellinger K. (1988). The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 51, 540–543. 10.1136/jnnp.51.4.540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Juvin L., Gratsch S., Trillaud-Doppia E., Gariepy J. F., Buschges A., Dubuc R. (2016). A specific population of reticulospinal neurons controls the termination of locomotion. Cell Rep. 15, 2377–2386. 10.1016/j.celrep.2016.05.029 [DOI] [PubMed] [Google Scholar]
  62. Karachi C., Andre A., Bertasi E., Bardinet E., Lehericy S., Bernard F. A. (2012). Functional parcellation of the lateral mesencephalus. J. Neurosci. 32, 9396–9401. 10.1523/JNEUROSCI.0509-12.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Karachi C., Francois C. (2017). Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys. J. Neural Transm. 10.1007/s00702-017-1678-y. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  64. Karachi C., Grabli D., Bernard F. A., Tande D., Wattiez N., Belaid H., et al. (2010). Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J. Clin. Invest. 120, 2745–2754. 10.1172/JCI42642 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Kitahama K., Nagatsu I., Geffard M., Maeda T. (2000). Distribution of dopamine-immunoreactive fibers in the rat brainstem. J. Chem. Neuroanat. 18, 1–9. 10.1016/S0891-0618(99)00047-2 [DOI] [PubMed] [Google Scholar]
  66. Knight E. J., Testini P., Min H. K., Gibson W. S., Gorny K. R., Favazza C. P., et al. (2015). Motor and nonmotor circuitry activation induced by subthalamic nucleus deep brain stimulation in patients with parkinson disease: intraoperative functional magnetic resonance imaging for deep brain stimulation. Mayo Clin. Proc. 90, 773–785. 10.1016/j.mayocp.2015.03.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Kravitz A. V., Freeze B. S., Parker P. R., Kay K., Thwin M. T., Deisseroth K., et al. (2010). Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622–626. 10.1038/nature09159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kuo S. H., Kenney C., Jankovic J. (2008). Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov. Disord. 23, 616–619. 10.1002/mds.21917 [DOI] [PubMed] [Google Scholar]
  69. Lau B., Welter M. L., Belaid H., Fernandez Vidal S., Bardinet E., Grabli D., et al. (2015). The integrative role of the pedunculopontine nucleus in human gait. Brain 138, 1284–1296. 10.1093/brain/awv047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Lavoie B., Parent A. (1994). Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J. Comp. Neurol. 344, 232–241. 10.1002/cne.903440205 [DOI] [PubMed] [Google Scholar]
  71. Lee A. M., Hoy J. L., Bonci A., Wilbrecht L., Stryker M. P., Niell C. M. (2014). Identification of a brainstem circuit regulating visual cortical state in parallel with locomotion. Neuron 83, 455–466. 10.1016/j.neuron.2014.06.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Le Ray D., Brocard F., Bourcier-Lucas C., Auclair F., Lafaille P., Dubuc R. (2003). Nicotinic activation of reticulospinal cells involved in the control of swimming in lampreys. Eur. J. Neurosci. 17, 137–148. 10.1046/j.1460-9568.2003.02417.x [DOI] [PubMed] [Google Scholar]
  73. Le Ray D., Juvin L., Ryczko D., Dubuc R. (2011). Chapter 4–supraspinal control of locomotion: the mesencephalic locomotor region. Prog. Brain Res. 188, 51–70. 10.1016/B978-0-444-53825-3.00009-7 [DOI] [PubMed] [Google Scholar]
  74. Liu H. G., Zhang K., Yang A. C., Zhang J. G. (2015). Deep brain stimulation of the subthalamic and pedunculopontine nucleus in a patient with Parkinson's disease. J. Korean Neurosurg. Soc. 57, 303–306. 10.3340/jkns.2015.57.4.303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Macaya A., Munell F., Gubits R. M., Burke R. E. (1994). Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. U.S.A. 91, 8117–8121. 10.1073/pnas.91.17.8117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Marin O., Smeets W. J., Gonzalez A. (1997). Basal ganglia organization in amphibians: catecholaminergic innervation of the striatum and the nucleus accumbens. J. Comp. Neurol. 378, 50–69. [DOI] [PubMed] [Google Scholar]
  77. Marlinsky V. V., Voitenko L. P. (1991). The effect of procaine injection into the medullary reticular formation on forelimb muscle activity evoked by mesencephalic locomotor region and vestibular stimulation in the decerebrated guinea-pig. Neuroscience 45, 753–759. 10.1016/0306-4522(91)90287-X [DOI] [PubMed] [Google Scholar]
  78. Marti M. J., James C. J., Oo T. F., Kelly W. J., Burke R. E. (1997). Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17, 2030–2039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Masdeu J. C., Alampur U., Cavaliere R., Tavoulareas G. (1994). Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann. Neurol. 35, 619–621. 10.1002/ana.410350517 [DOI] [PubMed] [Google Scholar]
  80. Mazzone P., Paoloni M., Mangone M., Santilli V., Insola A., Fini M., et al. (2014). Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance. Gait Posture 40, 357–362. 10.1016/j.gaitpost.2014.05.002 [DOI] [PubMed] [Google Scholar]
  81. Mazzone P., Sposato S., Insola A., Scarnati E. (2013). The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery 73, 894–906; discussion 905–906. 10.1227/neu.0000000000000108 [DOI] [PubMed] [Google Scholar]
  82. McGeer E. G., McGeer P. L. (1984). Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum. Brain Res. 298, 339–342. 10.1016/0006-8993(84)91433-1 [DOI] [PubMed] [Google Scholar]
  83. Menard A., Auclair F., Bourcier-Lucas C., Grillner S., Dubuc R. (2007). Descending GABAergic projections to the mesencephalic locomotor region in the lamprey Petromyzon marinus. J. Comp. Neurol. 501, 260–273. 10.1002/cne.21258 [DOI] [PubMed] [Google Scholar]
  84. Mestre T. A., Sidiropoulos C., Hamani C., Poon Y. Y., Lozano A. M., Lang A. E., et al. (2016). Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease. Mov. Disord. 31, 1570–1574. 10.1002/mds.26710 [DOI] [PubMed] [Google Scholar]
  85. Moore S. T., MacDougall H. G., Gracies J. M., Ondo W. G. (2008). Locomotor response to levodopa in fluctuating Parkinson's disease. Exp. Brain Res. 184, 469–478. 10.1007/s00221-007-1113-y [DOI] [PubMed] [Google Scholar]
  86. Musienko P. E., Zelenin P. V., Lyalka V. F., Orlovsky G. N., Deliagina T. G. (2008). Postural performance in decerebrated rabbit. Behav. Brain Res. 190, 124–134. 10.1016/j.bbr.2008.02.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Neagu B., Tsang E., Mazzella F., Hamani C., Moro E., Hodaie M., et al. (2013). Pedunculopontine nucleus evoked potentials from subthalamic nucleus stimulation in Parkinson's disease. Exp. Neurol. 250, 221–227. 10.1016/j.expneurol.2013.09.018 [DOI] [PubMed] [Google Scholar]
  88. Noga B. R., Kettler J., Jordan L. M. (1988). Locomotion produced in mesencephalic cats by injections of putative transmitter substances and antagonists into the medial reticular formation and the pontomedullary locomotor strip. J. Neurosci. 8, 2074–2086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Noga B. R., Kriellaars D. J., Jordan L. M. (1991). The effect of selective brainstem or spinal cord lesions on treadmill locomotion evoked by stimulation of the mesencephalic or pontomedullary locomotor regions. J. Neurosci. 11, 1691–1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Nosko D., Ferraye M. U., Fraix V., Goetz L., Chabardes S., Pollak P., et al. (2015). Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial. J. Neurol. Neurosurg. Psychiatry 86, 674–679. 10.1136/jnnp-2013-307511 [DOI] [PubMed] [Google Scholar]
  91. Ohta Y., Grillner S. (1989). Monosynaptic excitatory amino acid transmission from the posterior rhombencephalic reticular nucleus to spinal neurons involved in the control of locomotion in lamprey. J. Neurophysiol. 62, 1079–1089. [DOI] [PubMed] [Google Scholar]
  92. Orlovskii G. N. (1970). [Work of reticulo-spinal neurons during locomotion]. Biofizika 15, 728–737. [PubMed] [Google Scholar]
  93. Pedersen V., Schmidt W. J. (2000). The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs. Neurotox. Res. 2, 179–204. 10.1007/BF03033793 [DOI] [PubMed] [Google Scholar]
  94. Perez-Fernandez J., Stephenson-Jones M., Suryanarayana S. M., Robertson B., Grillner S. (2014). Evolutionarily conserved organization of the dopaminergic system in lamprey: SNc/VTA afferent and efferent connectivity and D2 receptor expression. J. Comp. Neurol. 522, 3775–3794. 10.1002/cne.23639 [DOI] [PubMed] [Google Scholar]
  95. Peterson D. S., Pickett K. A., Duncan R., Perlmutter J., Earhart G. M. (2014). Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS ONE 9:e90634. 10.1371/journal.pone.0090634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Piallat B., Chabardes S., Torres N., Fraix V., Goetz L., Seigneuret E., et al. (2009). Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience 158, 1201–1205. 10.1016/j.neuroscience.2008.10.046 [DOI] [PubMed] [Google Scholar]
  97. Pienaar I. S., Elson J. L., Racca C., Nelson G., Turnbull D. M., Morris C. M. (2013). Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am. J. Pathol. 183, 1826–1840. 10.1016/j.ajpath.2013.09.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Pienaar I. S., Gartside S. E., Sharma P., De Paola V., Gretenkord S., Withers D., et al. (2015a). Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Mol. Neurodegener. 10:47. 10.1186/s13024-015-0044-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Pienaar I. S., Harrison I. F., Elson J. L., Bury A., Woll P., Simon A. K., et al. (2015b). An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. Brain Struct. Funct. 220, 479–500. 10.1007/s00429-013-0669-5 [DOI] [PubMed] [Google Scholar]
  100. Pinching A. J., Powell T. P. (1971). Ultrastructural features of transneuronal cell degeneration in the olfactory system. J. Cell Sci. 8, 253–287. [DOI] [PubMed] [Google Scholar]
  101. Plaha P., Gill S. S. (2005). Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16, 1883–1887. 10.1097/01.wnr.0000187637.20771.a0 [DOI] [PubMed] [Google Scholar]
  102. Poirier L., Sourkes T. L. (1965). Influence of the substantia nigra on the catecholamine content of the striatum. Brain 88, 181–192. 10.1093/brain/88.1.181 [DOI] [PubMed] [Google Scholar]
  103. Pombal M. A., El Manira A., Grillner S. (1997). Afferents of the lamprey striatum with special reference to the dopaminergic system: a combined tracing and immunohistochemical study. J. Comp. Neurol. 386, 71–91. [PubMed] [Google Scholar]
  104. Puelles L., Verney C. (1998). Early neuromeric distribution of tyrosine-hydroxylase-immunoreactive neurons in human embryos. J. Comp. Neurol. 394, 283–308. [DOI] [PubMed] [Google Scholar]
  105. Rink E., Wullimann M. F. (2001). The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 889, 316–330. 10.1016/S0006-8993(00)03174-7 [DOI] [PubMed] [Google Scholar]
  106. Rinne J. O., Ma S. Y., Lee M. S., Collan Y., Roytta M. (2008). Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat. Disord. 14, 553–557. 10.1016/j.parkreldis.2008.01.006 [DOI] [PubMed] [Google Scholar]
  107. Rolland A. S., Tande D., Herrero M. T., Luquin M. R., Vazquez-Claverie M., Karachi C., et al. (2009). Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication. J. Neurochem. 110, 1321–1329. 10.1111/j.1471-4159.2009.06220.x [DOI] [PubMed] [Google Scholar]
  108. Roseberry T. K., Lee A. M., Lalive A. L., Wilbrecht L., Bonci A., Kreitzer A. C. (2016). Cell-type-specific control of brainstem locomotor circuits by basal ganglia. Cell 164, 526–537. 10.1016/j.cell.2015.12.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Rowe J., Khan A., Romanowski C., Isaac C., Khan S., Mair R., et al. (2016). Clinical experience with pedunculopontine nucleus stimulation in conditions with nigrostriatal disconnection. World Neurosurg. 89, 9–18. 10.1016/j.wneu.2015.11.054 [DOI] [PubMed] [Google Scholar]
  110. Ryczko D., Auclair F., Cabelguen J. M., Dubuc R. (2016a). The mesencephalic locomotor region sends a bilateral glutamatergic drive to hindbrain reticulospinal neurons in a tetrapod. J. Comp. Neurol. 524, 1361–1383. 10.1002/cne.23911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Ryczko D., Cone J. J., Alpert M. H., Goetz L., Auclair F., Dube C., et al. (2016b). A descending dopamine pathway conserved from basal vertebrates to mammals. Proc. Natl. Acad. Sci. U.S.A. 113, E2440–E2449. 10.1073/pnas.1600684113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Ryczko D., Dubuc R. (2013). The multifunctional mesencephalic locomotor region. Curr. Pharm. Des. 19, 4448–4470. 10.2174/1381612811319240011 [DOI] [PubMed] [Google Scholar]
  113. Ryczko D., Gratsch S., Auclair F., Dube C., Bergeron S., Alpert M. H., et al. (2013). Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proc. Natl. Acad. Sci. U.S.A. 110, E3235–E3242. 10.1073/pnas.1301125110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Saavedra J. M., Kvetnansky R., Kopin I. J. (1979). Adrenaline, noradrenaline and dopamine levels in specific brain stem areas of acutely immobilized rats. Brain Res. 160, 271–280. 10.1016/0006-8993(79)90424-4 [DOI] [PubMed] [Google Scholar]
  115. Sano I., Gamo T., Kakimoto Y., Taniguchi K., Takesada M., Nishinuma K. (1959). Distribution of catechol compounds in human brain. Biochim. Biophys. Acta 32, 586–587. 10.1016/0006-3002(59)90652-3 [DOI] [PubMed] [Google Scholar]
  116. Scarnati E., Campana E., Pacitti C. (1984). Pedunculopontine-evoked excitation of substantia nigra neurons in the rat. Brain Res. 304, 351–361. 10.1016/0006-8993(84)90339-1 [DOI] [PubMed] [Google Scholar]
  117. Scarnati E., Proia A., Di Loreto S., Pacitti C. (1987). The reciprocal electrophysiological influence between the nucleus tegmenti pedunculopontinus and the substantia nigra in normal and decorticated rats. Brain Res. 423, 116–124. 10.1016/0006-8993(87)90831-6 [DOI] [PubMed] [Google Scholar]
  118. Schrader C., Seehaus F., Capelle H. H., Windhagen A., Windhagen H., Krauss J. K. (2013). Effects of pedunculopontine area and pallidal DBS on gait ignition in Parkinson's disease. Brain Stimul. 6, 856–859. 10.1016/j.brs.2013.05.005 [DOI] [PubMed] [Google Scholar]
  119. Seidel K., Mahlke J., Siswanto S., Kruger R., Heinsen H., Auburger G., et al. (2015). The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Brain Pathol. 25, 121–135. 10.1111/bpa.12168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Semba K., Fibiger H. C. (1992). Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol. 323, 387–410. 10.1002/cne.903230307 [DOI] [PubMed] [Google Scholar]
  121. Shik M. L., Severin F. V., Orlovskii G. N. (1966). [Control of walking and running by means of electric stimulation of the midbrain]. Biofizika 11, 659–666. [PubMed] [Google Scholar]
  122. Shine J. M., Matar E., Ward P. B., Bolitho S. J., Gilat M., Pearson M., et al. (2013). Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 136, 1204–1215. 10.1093/brain/awt049 [DOI] [PubMed] [Google Scholar]
  123. Sholomenko G. N., Funk G. D., Steeves J. D. (1991). Avian locomotion activated by brainstem infusion of neurotransmitter agonists and antagonists. II. gamma-Aminobutyric acid. Exp. Brain Res. 85, 674–681. 10.1007/BF00231753 [DOI] [PubMed] [Google Scholar]
  124. Sirota M. G., Di Prisco G. V., Dubuc R. (2000). Stimulation of the mesencephalic locomotor region elicits controlled swimming in semi-intact lampreys. Eur. J. Neurosci. 12, 4081–4092. 10.1046/j.1460-9568.2000.00301.x [DOI] [PubMed] [Google Scholar]
  125. Smeets W. J., Marin O., Gonzalez A. (2000). Evolution of the basal ganglia: new perspectives through a comparative approach. J. Anat. 196(Pt 4), 501–517. 10.1046/j.1469-7580.2000.19640501.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Smetana R., Juvin L., Dubuc R., Alford S. (2010). A parallel cholinergic brainstem pathway for enhancing locomotor drive. Nat. Neurosci. 13, 731–738. 10.1038/nn.2548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Snijders A. H., Leunissen I., Bakker M., Overeem S., Helmich R. C., Bloem B. R., et al. (2011). Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 134, 59–72. 10.1093/brain/awq324 [DOI] [PubMed] [Google Scholar]
  128. Snijders A. H., Takakusaki K., Debu B., Lozano A. M., Krishna V., Fasano A., et al. (2016). Physiology of freezing of gait. Ann. Neurol. 80, 644–659. 10.1002/ana.24778 [DOI] [PubMed] [Google Scholar]
  129. Sourkes T. L., Poirier L. (1965). Influence of the substantia nigra on the concentration of 5-hydroxytryptamine and dopamine of the striatum. Nature 207, 202–203. 10.1038/207202a0 [DOI] [PubMed] [Google Scholar]
  130. Stack E., Ashburn A. (2008). Dysfunctional turning in Parkinson's disease. Disabil. Rehabil. 30, 1222–1229. 10.1080/09638280701829938 [DOI] [PubMed] [Google Scholar]
  131. Steeves J. D., Jordan L. M. (1980). Localization of a descending pathway in the spinal cord which is necessary for controlled treadmill locomotion. Neurosci. Lett. 20, 283–288. 10.1016/0304-3940(80)90161-5 [DOI] [PubMed] [Google Scholar]
  132. Stefani A., Peppe A., Galati S., Bassi M. S., D'Angelo V., Pierantozzi M. (2013). The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front. Neurol. 4:68. 10.3389/fneur.2013.00068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Steiniger B., Kretschmer B. D. (2003). Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus. Exp. Brain Res. 149, 422–430. 10.1007/s00221-003-1382-z [DOI] [PubMed] [Google Scholar]
  134. Steininger T. L., Rye D. B., Wainer B. H. (1992). Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol. 321, 515–543. 10.1002/cne.903210403 [DOI] [PubMed] [Google Scholar]
  135. Tard C., Delval A., Devos D., Lopes R., Lenfant P., Dujardin K., et al. (2015). Brain metabolic abnormalities during gait with freezing in Parkinson's disease. Neuroscience 307, 281–301. 10.1016/j.neuroscience.2015.08.063 [DOI] [PubMed] [Google Scholar]
  136. Tattersall T. L., Stratton P. G., Coyne T. J., Cook R., Silberstein P., Silburn P. A., et al. (2014). Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat. Neurosci. 17, 449–454. 10.1038/nn.3642 [DOI] [PubMed] [Google Scholar]
  137. Thevathasan W., Pogosyan A., Hyam J. A., Jenkinson N., Foltynie T., Limousin P., et al. (2012). Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism. Brain 135, 148–160. 10.1093/brain/awr315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Vercruysse S., Leunissen I., Vervoort G., Vandenberghe W., Swinnen S., Nieuwboer A. (2015). Microstructural changes in white matter associated with freezing of gait in Parkinson's disease. Mov. Disord. 30, 567–576. 10.1002/mds.26130 [DOI] [PubMed] [Google Scholar]
  139. Versteeg D. H., Van Der Gugten J., De Jong W., Palkovits M. (1976). Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 113, 563–574. 10.1016/0006-8993(76)90057-3 [DOI] [PubMed] [Google Scholar]
  140. Wang M., Jiang S., Yuan Y., Zhang L., Ding J., Wang J., et al. (2016). Alterations of functional and structural connectivity of freezing of gait in Parkinson's disease. J. Neurol. 263, 1583–1592. 10.1007/s00415-016-8174-4 [DOI] [PubMed] [Google Scholar]
  141. Weiss P. H., Herzog J., Potter-Nerger M., Falk D., Herzog H., Deuschl G., et al. (2015). Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers. Mov. Disord. 30, 1121–1125. 10.1002/mds.26229 [DOI] [PubMed] [Google Scholar]
  142. Welter M. L., Demain A., Ewenczyk C., Czernecki V., Lau B., El Helou A., et al. (2015). PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. J. Neurol. 262, 1515–1525. 10.1007/s00415-015-7744-1 [DOI] [PubMed] [Google Scholar]
  143. Windels F., Thevathasan W., Silburn P., Sah P. (2015). Where and what is the PPN and what is its role in locomotion? Brain 138, 1133–1134. 10.1093/brain/awv059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Wullimann M. F. (2014). Ancestry of basal ganglia circuits: new evidence in teleosts. J. Comp. Neurol. 522, 2013–2018. 10.1002/cne.23525 [DOI] [PubMed] [Google Scholar]
  145. Xiao C., Cho J. R., Zhou C., Treweek J. B., Chan K., McKinney S. L., et al. (2016). Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways. Neuron 90, 333–347. 10.1016/j.neuron.2016.03.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Yamamoto K., Vernier P. (2011). The evolution of dopamine systems in chordates. Front. Neuroanat. 5:21. 10.3389/fnana.2011.00021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Yeo S. S., Lee D. G., Choi B. Y., Chang C. H., Jung Y. J., Kim S. H., et al. (2012). Neural connectivity of the pedunculopontine nucleus in relation to walking ability in chronic patients with intracerebral hemorrhage. Eur. Neurol. 67, 226–231. 10.1159/000335248 [DOI] [PubMed] [Google Scholar]
  148. Yoo J. H., Zell V., Wu J., Punta C., Ramajayam N., Shen X., et al. (2017). Activation of pedunculopontine glutamate neurons is reinforcing. J. Neurosci. 37, 38–46. 10.1523/JNEUROSCI.3082-16.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Youn J., Lee J. M., Kwon H., Kim J. S., Son T. O., Cho J. W. (2015). Alterations of mean diffusivity of pedunculopontine nucleus pathway in Parkinson's disease patients with freezing of gait. Parkinsonism Relat. Disord. 21, 12–17. 10.1016/j.parkreldis.2014.10.003 [DOI] [PubMed] [Google Scholar]
  150. Zweig R. M., Jankel W. R., Hedreen J. C., Mayeux R., Price D. L. (1989). The pedunculopontine nucleus in Parkinson's disease. Ann. Neurol. 26, 41–46. 10.1002/ana.410260106 [DOI] [PubMed] [Google Scholar]
  151. Zweig R. M., Whitehouse P. J., Casanova M. F., Walker L. C., Jankel W. R., Price D. L. (1987). Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann. Neurol. 22, 18–25. 10.1002/ana.410220107 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES